Lu Victor M, Duvall Julia B, Phan Kevin, Jonker Benjamin P
a Sydney Medical School, The University of Sydney , Sydney , NSW , Australia.
b Department of Neuroscience , Johns Hopkins , Baltimore , MD , USA.
Br J Neurosurg. 2018 Aug;32(4):355-364. doi: 10.1080/02688697.2018.1472213. Epub 2018 May 10.
Procedures to treat medically refractory trigeminal neuralgia (MRTN) include stereotactic radiosurgery (SRS) and microvascular decompression (MVD). The aim of this study was to compare outcomes of SRS versus MVD in the treatment of MRTN, with a subgroup focus on those being treated for the first time.
Search strategy was performed using the PRISMA guidelines for article identification, screening, eligibility and inclusion. Relevant articles were identified from six electronic databases from their inception to June 2017. These articles were screened against established criteria for inclusion into this study. Meta-analysis was conducted by pooling results with odds ratios and subgroup analysis.
From 13 relevant studies identified, 683 patients treated by SRS were compared with 670 patients treated by MVD for MRTN. Overall, the significant findings were that compared to MVD, SRS was associated with lower rates of short-term (OR = 0.16; 95%CI = 0.11-0.22; p < .001) and long-term pain freedom (OR = 0.31; 95%CI = 0.22-0.44; p < .001), fewer postoperative complications (OR = 0.06; 95%CI = 0.02-0.16; p < .001), more facial numbness and dysesthesia (OR = 1.64; 95%CI = 1.08-2.49; p = .02), and more pain recurrence (OR = 2.28; 95%CI = 1.32-3.93; p = .003). These trends were all reflected in MRTN patients being treated for the first time.
Both SRS and MVD alleviate pain in MRTN patients. MVD results in superior rates of short- and long-term pain relief, facial numbness and dysesthesia control, and less recurrence amongst those in whom pain freedom was achieved, at the cost of greater postoperative complications when compared to SRS. Although no significant difference was found in terms of the need for retreatment surgery, there was a trend towards less procedures favoring MVD. First treatment by either technique represents the overall trends reported.
治疗药物难治性三叉神经痛(MRTN)的方法包括立体定向放射外科手术(SRS)和微血管减压术(MVD)。本研究的目的是比较SRS和MVD治疗MRTN的疗效,重点关注首次接受治疗的亚组患者。
采用PRISMA指南进行文献检索,以确定、筛选、评估文章的合格性和纳入情况。从6个电子数据库中检索自数据库建立至2017年6月的相关文章。根据既定标准对这些文章进行筛选,以纳入本研究。通过合并比值比结果进行荟萃分析和亚组分析。
从13项相关研究中,将683例接受SRS治疗的MRTN患者与670例接受MVD治疗的患者进行比较。总体而言,显著的发现是,与MVD相比,SRS的短期(OR = 0.16;95%CI = 0.11 - 0.22;p <.001)和长期疼痛缓解率较低(OR = 0.31;95%CI = 0.22 - 0.44;p <.001),术后并发症较少(OR = 0.06;95%CI = 0.02 - 0.16;p <.001),面部麻木和感觉异常较多(OR = 1.64;95%CI = 1.08 - 2.49;p = 0.02),疼痛复发较多(OR = 2.28;95%CI = 1.32 - 3.93;p = 0.003)。这些趋势在首次接受治疗的MRTN患者中均有体现。
SRS和MVD均可缓解MRTN患者的疼痛。与SRS相比,MVD的短期和长期疼痛缓解率、面部麻木和感觉异常控制率更高,疼痛缓解患者的复发率更低,但术后并发症更多。尽管在再次手术需求方面未发现显著差异,但存在更倾向于MVD的手术操作更少的趋势。两种技术首次治疗均呈现所报告的总体趋势。